Roche Seen Offering NICE Further Price Cut For MS Drug Ocrevus

 
• By Sten Stovall

UK HTA provisionally tells Roche price for supplying MS blockbuster Ocrevus to the NHS not good enough – 'try again'.

MS
NICE Says Roche’s Offered Price For MS Drug Ocrevus Still Too High • Source: Shutterstock

More from New Products

More from Scrip